Although interim analyses in cancer clinical trials are commonplace, clinical trials are usually designed with the implicit assumption that data analysis will occur only after the trial is completed. The design of randomized trials with planned interim analyses, "group sequential trials," is described and examples are given. A method to redesign trials in which unplanned interim analyses have been undertaken is described. Planned interim analysis should be considered whenever a cancer clinical trial is designed.

© 1987 by American Society of Clinical Oncology

COMPANION ARTICLES

No companion articles

ARTICLE CITATION

DOI: 10.1200/JCO.1987.5.9.1485 Journal of Clinical Oncology 5, no. 9 (September 01, 1987) 1485-90.

Published online September 22, 2016.

PMID: 3625263

ASCO Career Center